WHO panel pushes for genome editing research registry

A WHO advisory committee has spoken out against clinical applications of human germline genome editing. The panel, which formed in the wake of China’s germline modification scandal, wants WHO to create a central registry on human genome editing research as part of an effort to boost global governance of the field.